**Core Concept**
Neuromuscular blocking agents (NMBAs) are a class of medications that act on the neuromuscular junction to induce muscle paralysis. They work by blocking the action of acetylcholine at the nicotinic acetylcholine receptors on the muscle endplate, preventing muscle contraction.

**Why the Correct Answer is Right**
The correct answer is a group of drugs that specifically inhibit acetylcholinesterase, the enzyme responsible for breaking down acetylcholine at the neuromuscular junction. This leads to an accumulation of acetylcholine and overstimulation of nicotinic acetylcholine receptors, resulting in muscle paralysis. Examples of these drugs include succinylcholine and mivacurium.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it refers to a group of drugs that act on the central nervous system, such as benzodiazepines, which are used for their sedative and anxiolytic effects.
* **Option B:** This option is incorrect because it refers to a group of drugs that act on the autonomic nervous system, such as beta-blockers, which are used to treat hypertension and heart failure.
* **Option C:** This option is incorrect because it refers to a group of drugs that act on the muscarinic acetylcholine receptors, such as anticholinergics, which are used to treat conditions such as Parkinson's disease and gastrointestinal disorders.

**Clinical Pearl / High-Yield Fact**
It's essential to note that NMBAs can be divided into two categories: depolarizing and non-depolarizing agents. Depolarizing agents, such as succinylcholine, work by activating nicotinic acetylcholine receptors, while non-depolarizing agents, such as rocuronium and vecuronium, work by blocking nicotinic acetylcholine receptors.

**Correct Answer: C. Non-depolarizing neuromuscular blockers**